- Home
- KRRO vs FMN Comparison
KRRO vs FMN Comparison
Compare KRRO & FMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KRRO | FMN |
|---|---|---|
| Founded | 2014 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 105.0M | 87.8M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | KRRO | FMN |
|---|---|---|
| Price | $11.85 | $11.23 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $47.10 | N/A |
| AVG Volume (30 Days) | ★ 150.3K | 24.5K |
| Earning Date | 06-17-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.86% |
| EPS Growth | ★ 82.35 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,271,000.00 | N/A |
| Revenue This Year | $145.97 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.20 | $10.11 |
| 52 Week High | $55.89 | $11.38 |
Technical Indicators
Market Signals| Indicator | KRRO | FMN |
|---|---|---|
| Relative Strength Index (RSI) | 52.87 | 46.37 |
| Support Level | $10.55 | $10.98 |
| Resistance Level | $12.54 | $11.29 |
| Average True Range (ATR) | 0.81 | 0.11 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 56.73 | 68.93 |
Price Performance
Historical ComparisonAbout KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
About FMN Federated Hermes Premier Municipal Income Fund
Federated Hermes Premier Municipal Income Fund is a United States-based diversified, closed-end management investment company. The investment objective of the fund is to provide current income exempt from federal income tax, including the federal alternative minimum tax by investing in long-term, tax exempt municipal bonds diversified among states, sectors and issuers. Its portfolio of investments comprises different sectors such as hospitals, toll road, senior care, airport, tobacco, and other sectors.